High blood pressure pill may raise skin cancer risk: Health Canada
Advertisement
Read this article for free:
or
Already have an account? Log in here »
To continue reading, please subscribe:
Digital Subscription
One year of digital access for only $205*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*First annual payment billed as $205.00 + GST for one year. This annual subscription will automatically renew at $233.00 + GST every 52 weeks (10% off the regular annual price of $259.35). Offer available to new and qualified returning subscribers only. Cancel any time.
To continue reading, please subscribe:
Add Free Press access to your Brandon Sun subscription for only an additional
$1 for the first 4 weeks*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Your next Brandon Sun subscription payment will increase by $1.00 and you will be charged $17.95 plus GST for four weeks. After four weeks, your payment will increase to $24.95 plus GST every four weeks.
Read unlimited articles for free today:
or
Already have an account? Log in here »
Hey there, time traveller!
This article was published 31/01/2019 (2774 days ago), so information in it may no longer be current.
TORONTO – Health Canada says prolonged use of a drug commonly prescribed for high blood pressure could increase a person’s risk of developing non-melanoma skin cancer.
Hydrochlorothiazide is a diuretic, or water pill, that is also prescribed to reduce fluid retention related to heart failure and some kidney and liver problems.
A safety review by Health Canada found that taking the medication can make skin more sensitive to ultraviolet radiation from sunlight and tanning equipment.
The review of research evidence suggests patients taking the drug for more than three years could have at least a four-fold higher risk of developing non-melanoma skin cancer.
However, Health Canada says that because of limitations in the studies, such as a lack of patient data on sun exposure and severity, there is uncertainty regarding the findings.
Even so, people taking hydrochlorothiazide are advised to limit UV exposure and to seek medical attention if they identify new skin lesions or changes in moles.
The federal department says doctors should consider alternative medications for patients with an elevated risk of non-melanoma skin cancer, including those with fair skin or a personal or family history of skin cancer.
